Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

May 31, 2015

Conditions
Diabetes MellitusDiabetes Mellitus, Type 1Glucose Metabolism DisordersEndocrine System DiseasesAutoimmune Diseases
Interventions
DEVICE

Overnight closed-loop

The closed-loop system is purpose-built and comprises a hand-held computer containing a model predictive control (MPC) based glucose control algorithm and communicating with the CGM device and the insulin pump.

DEVICE

Real-time CGM alone

Subject glucose level controlled by usual insulin pump therapy in conjunction with real time continuous glucose monitoring (CGM)

Trial Locations (3)

CB2 0QQ

University of Cambridge, Cambridge

LS9 7TF

Leeds Teaching Hospitals, Leeds

NW1 2BU

University College London Hospital, London

All Listed Sponsors
collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

University College London Hospitals

OTHER

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

lead

University of Cambridge

OTHER

NCT01778348 - Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting | Biotech Hunter | Biotech Hunter